Octenidine hydrochloride in hydatid disease

Hydatid disease remains a significant health issue in many developing regions. Despite its prevalence, effective and safe treatment options remain limited. Prior research has shown that hydatid cysts contain protoscoleces that can cause disease if not properly neutralized during surgical removal. Established treatments include saline solutions, but these may not always be sufficient. Researchers have explored alternative agents to improve scolicidal efficacy. However, the effectiveness of octenidine hydrochloride in this context was not well established. This gap motivated the investigation into octenidine's potential as a scolicidal agent. No prior work had resolved whether lower concentrations of octenidine could achieve the same results as undiluted forms. This study aimed to address these uncertainties.

The study aimed to assess the scolicidal activity of octenidine hydrochloride in different concentrations and exposure times. Hydatid disease requires effective protoscolex neutralization during surgery to prevent recurrence. Current methods may not fully eliminate protoscoleces, prompting the need for alternative solutions. The researchers focused on octenidine, a known antiseptic, to determine its efficacy in this context. They tested undiluted, 1%, and 0.1% concentrations of octenidine. The goal was to compare these with 20% saline, a standard reference. By varying exposure times from 5 to 60 minutes, the team sought to identify the minimum effective concentration and duration. This approach aimed to determine whether octenidine could serve as a viable alternative or supplement to existing protocols.

The researchers collected hydatid cyst fluid and allowed it to settle for one hour to isolate cystic sand. They then added octenidine hydrochloride in three concentrations: undiluted, 1%, and 0.1%. Each concentration was tested at exposure times ranging from 5 to 60 minutes. Protoscolex viability was assessed after each exposure period. The same exposure times were applied to 20% saline as a control. The study used a standardized in vitro setup to ensure consistency. Researchers evaluated scolicidal effects by observing protoscolex motility and morphology. They compared the results across all concentrations and exposure times. This method allowed them to determine the minimum effective concentration and duration for each octenidine solution.

Undiluted octenidine demonstrated strong scolicidal activity after 15 minutes of exposure. At this point, it outperformed 20% saline, which required longer exposure times to achieve similar effects. One percent octenidine showed scolicidal effects after 30 minutes of exposure. However, 0.1% octenidine did not achieve sufficient scolicidal activity even after 60 minutes. The study found that the undiluted and 1% solutions were more effective than the lower concentration. The 20% saline solution served as a benchmark but was less effective than undiluted octenidine at shorter exposure times. These findings suggest that higher concentrations of octenidine are more effective for scolicidal purposes. The results indicate that undiluted and 1% octenidine may be suitable for clinical use.

The authors concluded that undiluted and 1% octenidine hydrochloride may be suitable for scolicidal use in hydatid disease treatment. The study showed that undiluted octenidine achieved strong scolicidal effects after 15 minutes. One percent octenidine required 30 minutes to achieve similar results. The 0.1% concentration was ineffective even after one hour. These findings suggest that higher concentrations are more effective for this purpose. The results also indicate that undiluted octenidine outperformed 20% saline at shorter exposure times. The authors propose that these concentrations could be considered for clinical application. However, they did not claim that octenidine is essential or the only viable option for scolicidal treatment.